2061 THE IMPACT OF RECENT SCREENING RECOMMENDATIONS ON PROSTATE CANCER SCREENING IN A LARGE HEALTH SYSTEM (2013)

You have accessJournal of UrologyProstate Cancer: Detection & Screening (IV)1 Apr 20132061 THE IMPACT OF RECENT SCREENING RECOMMENDATIONS ON PROSTATE CANCER SCREENING IN A LARGE HEALTH SYSTEM Afshin Aslani, Benjamin Johnson, Lee Ponsky, Edward Cherullo, and Robert Abouassaly Afshin AslaniAfshin Aslani Cleveland, OH More articles by this author , Benjamin JohnsonBenjamin Johnson Cleveland, OH More articles by this author , Lee PonskyLee Ponsky Cleveland, OH More articles by this author , Edward CherulloEdward Cherullo Cleveland, OH More articles by this author , and Robert AbouassalyRobert Abouassaly Cleveland, OH More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2013.02.2480AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES The U.S. Preventative Services Task Force (USPSTF) recently recommended against routine prostate cancer screening, stating the risks of screening outweigh the benefits. The aim of our study was to determine impact this recommendation had on prostate cancer screening in a large university-based health system. METHODS We obtained data on all screening PSAs performed at the University Hospitals Case Medical Center and affiliated hospitals in Northeastern Ohio from January 2008 to August 2012. The total number of PSAs ordered over time, adjusted for patient volume, was examined by fitting a regression line. Trend over time was examined overall, and stratified by location (urban, suburban or rural), patient age, and ordering provider type (primary care vs. urology). RESULTS Overall 42,211 screening PSAs were performed from January 2008 to August 2012. The majority of these were ordered by internal medicine (47.7%), followed by family medicine (26.8%) and urology (9.2%). The number of screening PSAs increased over time until May 2012, the date the USPSTF issued its final recommendation, after which there appeared to be a significant decrease (Figure 1). The greatest decrease in PSA screening was observed in the urban teaching hospital, primary care, and in patients of intermediate age group (50-59 years and 70-79 years). CONCLUSIONS In the short term, the USPSTF recommendations appeared to negatively impact prostate cancer screening. The greatest impact appeared to be among primary care physicians and in patients in the intermediate age group. Further study is needed to determine the long-term effects of these recommendations on screening, diagnosis, treatment and prognosis of this prevalent malignancy. © 2013 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 189Issue 4SApril 2013Page: e846 Advertisement Copyright & Permissions© 2013 by American Urological Association Education and Research, Inc.MetricsAuthor Information Afshin Aslani Cleveland, OH More articles by this author Benjamin Johnson Cleveland, OH More articles by this author Lee Ponsky Cleveland, OH More articles by this author Edward Cherullo Cleveland, OH More articles by this author Robert Abouassaly Cleveland, OH More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...